Integrated Biopharma, Inc. last reported quarterly results on May 8, 2026, for Q3 FY2026 (the quarter ended Mar 31, 2026): revenue of $10.1 million (-27.5% year over year) and diluted EPS of -$0.03. It usually reports 38–44 days after a quarter ends.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 38–44 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
May 8, 2026
38 days after quarter end
|
Q3 FY2026
ended Mar 31, 2026
|
10
-27.5%
|
-1
-237.0%
|
-0.03
-250.0%
|
|
Feb 11, 2026
42 days after quarter end
|
Q2 FY2026
ended Dec 31, 2025
|
11
-10.6%
|
-1
-756.9%
|
-0.03
-400.0%
|
|
Nov 10, 2025
41 days after quarter end
|
Q1 FY2026
ended Sep 30, 2025
|
13
-6.8%
|
0
-52.5%
|
0.00
-100.0%
|
|
May 14, 2025
44 days after quarter end
|
Q3 FY2025
ended Mar 31, 2025
|
14
+6.1%
|
1
+114.4%
|
0.02
+100.0%
|
|
Feb 13, 2025
44 days after quarter end
|
Q2 FY2025
ended Dec 31, 2024
|
13
+9.6%
|
0
+130.4%
|
0.01
|
|
Nov 14, 2024
45 days after quarter end
|
Q1 FY2025
ended Sep 30, 2024
|
14
+5.4%
|
0
+539.0%
|
0.01
|
|
May 10, 2024
40 days after quarter end
|
—
ended Mar 31, 2024
|
—
|
—
|
—
|
|
Feb 12, 2024
43 days after quarter end
|
—
ended Dec 31, 2023
|
—
|
—
|
—
|
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INBP (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Hillside, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1016504
- Former names
- INTEGRATED HEALTH TECHNOLOGIES INC (until Apr 16, 2003); CHEM INTERNATIONAL INC (until May 14, 2002)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.